Sagimet Biosciences Inc.
USD6.79
-0.40 (-5.56%)
CEO
David A. Happel
IPO Date
2023-07-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.06
Prev. Close
$7.19
Day Low
$6.57
Day High
$7.07
52W Low
$3.83
52W High
$11.41
Market Cap
$0.22B
Volume
0.92M
| 35,000 |
| $7.27 |
| 1 Jun 2026 | Rozek Elizabeth | Chief Legal & Admin. Officer | A-Award | Acquired | 100,000 | $7.27 |
| 1 Jun 2026 | Happel David | director, officer: President & CEO | A-Award | Acquired | 300,000 | $7.27 |
| 14 May 2026 | Grauer Andreas | Chief Medical Officer | A-Award | Acquired | 264,759 | $6.44 |
| 14 May 2026 | Grauer Andreas | officer | Disposed | 0 | $0.00 |
| 20 Feb 2026 | Rozek Elizabeth | Chief Legal & Admin. Officer | A-Award | Acquired | 44,000 | $0.00 |
| 20 Feb 2026 | Rozek Elizabeth | Chief Legal & Admin. Officer | A-Award | Acquired | 88,000 | $5.38 |
| 20 Feb 2026 | Martins Eduardo Bruno | Chief Medical Officer | A-Award | Acquired | 88,000 | $5.38 |
| 20 Feb 2026 | Martins Eduardo Bruno | Chief Medical Officer | A-Award | Acquired | 44,000 | $0.00 |